Article

Lessons from Recent Advances in Ischemic Stroke Management and Targeting Kv2.1 for Neuroprotection

2020-08-04

Abstract excerpt

Achieving neuroprotection in ischemic stroke patients has been a multi-decade medical challenge. Numerous clinical trials were discontinued in futility and many were terminated in response to deleterious treatment effects. Recently however, several positive reports have generated the much-needed excitement surrounding stroke therapy. In this review, we describe the clinical studies that significantly expanded the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 544c7b30-0fdb-5d2f-a343-c995fcc6cd8b
DOI: 10.20944/preprints202008.0094.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Lessons from Recent Advances in Ischemic Stroke Management and Targeting Kv2.1 for NeuroprotectionDOI 10.20944/preprints202008.0094.v1Read

Update on cell therapy for stroke.Semantic proximity Read

The effects of IRL-1620 in post-ischemic brain injury: A systematic review of experimental studiesSemantic proximity Read

Mitochondrial Targets for StrokeSemantic proximity Read

Direct neuronal protection by the protease-activated receptor PAR4 antagonist ML354 after experimental stroke in miceSemantic proximity Read

Kv1.3 blockade alleviates white matter injury through reshaping M1/M2 phenotypes after intracerebral hemorrhageSemantic proximity Read

Methodological Approaches to Experimental Evaluation of Neuroprotective Action of Potential DrugsSemantic proximity Read

Endovascular thrombectomy for the treatment of large ischemic stroke: a systematic review and meta-analysis of randomized control trialsSemantic proximity Read

Cell Therapy for Ischemic Stroke: How to Turn a Promising Preclinical Research into a Successful Clinical StorySemantic proximity Read

Trick or Treat(ment): Should We Still Fear Reperfusion Therapy in Anticoagulated Stroke Patients?Semantic proximity Read

Reperfusion thrombolytic therapy for ischemic stroke in patients on non-vitamin K antagonist oral anticoagulants: study protocol of a phase II randomized clinical trialSemantic proximity Read

Remote Ischemic Perconditioning and 90-Day Cognitive Outcomes After Acute Ischemic Stroke: A REMOTE-CAT SubstudySemantic proximity Read

Kir6.2-containing ATP-sensitive potassium channels protect cortical neurons from ischemic/anoxic injury in vitro and in vivo.Semantic proximity Read